Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Hirva Mamdani

Dr. Hirva Mamdani

Thoracic Oncologist

Dr. Hirva Mamdani is a respected medical oncologist at Barbara Ann Karmanos Cancer Institute in Detroit. She specializes in the treatment of thoracic malignancies, including lung cancer and pleural mesothelioma.

Get in touch
Jump to a Topic:

About Hirva Mamdani

Accolades
  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Immunotherapy icon

    Immunotherapy

  • Research Excellence icon

    Excellence in Research

Get to Know Dr. Hirva Mamdani

Medical oncologist Dr. Hirva Mamdani was raised in a family of physicians, which sparked her passion for working tirelessly toward new and better treatments for cancer patients.

Mamdani specializes in thoracic oncology, particularly lung cancer and mesothelioma, at the Barbara Ann Karmanos Cancer Institute. She focuses her research on improving therapeutics for these tough-to-treat malignancies.

“In this field, you are constantly thinking about the science of cancer, and then applying that science and knowledge to find more treatment options for the patients,” she said.

Much of Mamdani’s work involves immunotherapy combinations and personalization of treatment, giving each patient the best chance to succeed.

The Karmanos Cancer Institute, which has more than 100 top doctors, is known for translational research that takes laboratory breakthroughs quickly into the clinic. It has become one of the most preferred cancer treatment facilities in the state of Michigan.

Specialties of Dr. Hirva Mamdani

Dr. Hirva Mamdani’s Experience and Medical Education

  • Barbara Ann Karmanos Cancer Institute
  • Indiana University School of Medicine (Fellowship)
  • Wayne State University (Residency)
  • M.P. Shah Medical College (India)
  • ASCO/AACR Methods in Clinical Cancer Research workshop

Awards and Other Recognitions

  • Indiana Oncology Society Research Fellow Award
  • Outstanding Senior Resident of the Year Award, Wayne State University
  • Investigator Award, Hoosier Cancer Research Network
  • American Society of Clinical Oncology (Member)
  • American Association for Cancer Research (Member)

Mesothelioma Clinical Trials Under Dr. Hirva Mamdani

  • A phase II clinical trial studying the immunotherapy combination of nivolumab (Opdivo) and ramucirumab (Cyramza) for patients with previously treated mesothelioma.

Publications of Dr. Hirva Mamdani

  • Mamdani, H. et al. (2017, May 29). Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma: Case Report and Review of Literature. Discover Medicine.
  • Mamdani, H. & Jalal, S. (2016, April). DNA repair in lung cancer: potential not yet reached. Journal of Lung Cancer Management.
  • Mamdani, H. et al. (2010). Advances and Controversies in the Management of Locally Advanced Gastro-esophageal Adenocarcinoma. Journal of Clinical Gastroenterology and Treatment.

Disclaimer: Dr. Hirva Mamdani has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 17, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now